IGFBP1 and Stroke: In another subcohort of the Cardiovascular Health Study (n = 2268), a higher two-hour s-IGFBP-1 post-oral glucose tolerance test, but not fasting s-IGFBP-1, was associated with increased risk of major health events (which included stroke) and mortality [24].